Wilson Ngai, Shuyu D. Li, Shelley MacNeil, Min Ren, Shuangxi Ji, Julia Koloskova. "First-line lenvatinib versus dabrafenib plus trametinib (D+T) in
                    <i>BRAF</i>
                    -mutated differentiated thyroid cancer (DTC): Insights from real-world data.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6052